Claudia M. Denkinger

Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study

Susan E. Dorman, Samuel G. Schumacher, David Alland et al. · The Lancet Infectious Diseases · 2017 · 691 citations · Full text

Public Health, Infectious Diseases, Internal Medicine +17

The New Xpert MTB/RIF Ultra: Improving Detection of <i>Mycobacterium tuberculosis</i> and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing

Soumitesh Chakravorty, Ann Marie Simmons, Mazhgan Rowneki et al. · mBio · 2017 · 657 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +16

Point-of-Care Testing for Infectious Diseases: Diversity, Complexity, and Barriers in Low- And Middle-Income Countries

Nitika Pant Pai, Caroline Vadnais, Claudia M. Denkinger et al. · PLoS Medicine · 2012 · 604 citations · Full text

Medicine, Infectious Disease Control, Infectious Diseases +12

A standardised method for interpreting the association between mutations and phenotypic drug resistance in<i>Mycobacterium tuberculosis</i>

Paolo Miotto, Belay Tessema, Elisa Tagliani et al. · European Respiratory Journal · 2017 · 333 citations · Full text

Life Sciences, Genetics, Microbiology +17

Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study

Nathan C. Bahr, Edwin Nuwagira, Emily E Evans et al. · The Lancet Infectious Diseases · 2017 · 320 citations · Full text

Public Health, Infectious Diseases, Microbiology +16